156 related articles for article (PubMed ID: 930750)
1. Treatment of parkinsonism.
Calne DB; Teychenne PF; Pfeiffer RF
Adv Exp Med Biol; 1977; 90():49-61. PubMed ID: 930750
[No Abstract] [Full Text] [Related]
2. [CB 154 in the treatment of Parkinson's disease. Results in combination with L-dopa and decarboxylase inhibitor].
Meco G; Casacchia M; Zamponi A; Agnoli A
Acta Neurol (Napoli); 1976; 31(4):479-48. PubMed ID: 1037427
[No Abstract] [Full Text] [Related]
3. Bromocriptine in Parkinsonism: long-term treatment, dose response, and comparison with levodopa.
Parkes JD; Debono AG; Marsden CD
J Neurol Neurosurg Psychiatry; 1976 Nov; 39(11):1101-8. PubMed ID: 1036999
[TBL] [Abstract][Full Text] [Related]
4. Comparison between lergotrile and bromocriptine in parkinsonism.
Teychenne PF; Pfeiffer RF; Bern SM; McInturff D; Calne DB
Ann Neurol; 1978 Apr; 3(4):319-24. PubMed ID: 666273
[TBL] [Abstract][Full Text] [Related]
5. Drugs for parkinsonism.
Med Lett Drugs Ther; 1986 Jun; 28(716):62-4. PubMed ID: 3713639
[No Abstract] [Full Text] [Related]
6. Dopamine agonists as primary treatment in Parkinson's disease.
Rinne UK
Adv Neurol; 1987; 45():519-23. PubMed ID: 3103394
[No Abstract] [Full Text] [Related]
7. Dystonia-Parkinson syndrome: differential effects of levodopa and dopamine agonists.
Klawans HL; Paleologos N
Clin Neuropharmacol; 1986; 9(3):298-302. PubMed ID: 3719575
[TBL] [Abstract][Full Text] [Related]
8. Lisuride in the treatment of Parkinsonism.
Schachter M; Sheehy MP; Parkes JD; Marsden CD
Acta Neurol Scand; 1980 Dec; 62(6):382-5. PubMed ID: 7468157
[TBL] [Abstract][Full Text] [Related]
9. Treatment of parkinsonism with bromocriptine.
Calne DB; Teychenne PF; Leigh PN; Bamji AN; Greenacre JK
Lancet; 1974 Dec; 2(7893):1355-6. PubMed ID: 4143315
[No Abstract] [Full Text] [Related]
10. Treatment of Parkinson's disease with 8-alpha-amino-ergoline, CU 32-085.
Schneider E; Hubener K; Fischer PA
Neurology; 1983 Apr; 33(4):468-72. PubMed ID: 6682193
[TBL] [Abstract][Full Text] [Related]
11. Studies with bromocriptine. Part 1. "On-off" phenomena.
Kartznel R; Calne DB
Neurology; 1976 Jun; 26(6 PT 1):508-10. PubMed ID: 945489
[TBL] [Abstract][Full Text] [Related]
12. Long-term use of dopamine agonists in Parkinson's disease.
Jankovic J
Clin Neuropharmacol; 1985; 8(2):131-40. PubMed ID: 3891082
[No Abstract] [Full Text] [Related]
13. Bromocriptine and levodopa (with or without carbidopa) in parkinsonism.
Kartzinel R; TEYCHENNE P; Gillespie MM; Perlow M; Gielen AC; Sadowsky DA; Calne DB
Lancet; 1976 Aug; 2(7980):272-5. PubMed ID: 59850
[TBL] [Abstract][Full Text] [Related]
14. Brain dopamine turnover and the relief of parkinsonism.
Rinne UK; Sonninen V; Marttila R
Adv Exp Med Biol; 1977; 90():267-75. PubMed ID: 930747
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of bromocriptine and levodopa in Parkinson's disease.
Duvoisin RC; Mendoza MM; Yahr MD
Adv Biochem Psychopharmacol; 1980; 23():271-5. PubMed ID: 7395618
[No Abstract] [Full Text] [Related]
16. Drugs for parkinsonism.
Med Lett Drugs Ther; 1979 May; 21(9):37-8. PubMed ID: 449844
[No Abstract] [Full Text] [Related]
17. Hyperthermia after discontinuance of levodopa and bromocriptine therapy: impaired dopamine receptors a possible cause.
Figà-Talamanca L; Gualandi C; Di Meo L; Di Battista G; Neri G; Lo Russo F
Neurology; 1985 Feb; 35(2):258-61. PubMed ID: 3969217
[TBL] [Abstract][Full Text] [Related]
18. Sinemet and the treatment of Parkinsonism.
Boshes B
Ann Intern Med; 1981 Mar; 94(3):364-70. PubMed ID: 7013595
[TBL] [Abstract][Full Text] [Related]
19. [Letter: Effect of bromocryptine on the fluctuations following dopa therapy. On-off phenomenon in parkinsonian patients].
Frattola L; Albizzati MG; Spano PF; Trabucchi M
Nouv Presse Med; 1976 Aug 28-Sep 4; 5(28):1761. PubMed ID: 958891
[No Abstract] [Full Text] [Related]
20. Adjuvant treatment of Parkinson's disease with dopamine agonists: open trial with bromocriptine and CU 32-085.
Jellinger K
J Neurol; 1982; 227(2):75-88. PubMed ID: 6180142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
